Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Mette Poehl"'
Autor:
Lill-Tove Busund, Roy M. Bremnes, Francesco Pezzella, Sigve Andersen, Torkjel M. Sandanger, Yury Kiselev, Khalid Al-Shibli, Olfred Hansen, Henrik J. Ditzel, Karen Ege Olsen, Mette Poehl, Marius Lund-Iversen, Aslaug Helland, Odd Terje Brustugun, Thomas K. Kilvaer, Samer Al-Saad, Elin Richardsen, Erna-Elise Paulsen, Sigurd M. Hald, Tom Donnem
Purpose: Immunoscore is a prognostic tool defined to quantify in situ immune cell infiltrates, which appears to be superior to the tumor–node–metastasis (TNM) classification in colorectal cancer. In non–small cell lung cancer (NSCLC), no immuno
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6e1dcc8aa6c7cc89aa28450d8e80b7a9
https://doi.org/10.1158/1078-0432.c.6524199.v1
https://doi.org/10.1158/1078-0432.c.6524199.v1
Autor:
Lill-Tove Busund, Roy M. Bremnes, Francesco Pezzella, Sigve Andersen, Torkjel M. Sandanger, Yury Kiselev, Khalid Al-Shibli, Olfred Hansen, Henrik J. Ditzel, Karen Ege Olsen, Mette Poehl, Marius Lund-Iversen, Aslaug Helland, Odd Terje Brustugun, Thomas K. Kilvaer, Samer Al-Saad, Elin Richardsen, Erna-Elise Paulsen, Sigurd M. Hald, Tom Donnem
Supplemental Table II. Prognostic clinicopathologic variables as predictors for DFS in 797 NSCLS (univariate analysis,log-rank test)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5f1c074a0a9179853cc8bb2ef1397caa
https://doi.org/10.1158/1078-0432.22459335
https://doi.org/10.1158/1078-0432.22459335
Autor:
Lill-Tove Busund, Roy M. Bremnes, Francesco Pezzella, Sigve Andersen, Torkjel M. Sandanger, Yury Kiselev, Khalid Al-Shibli, Olfred Hansen, Henrik J. Ditzel, Karen Ege Olsen, Mette Poehl, Marius Lund-Iversen, Aslaug Helland, Odd Terje Brustugun, Thomas K. Kilvaer, Samer Al-Saad, Elin Richardsen, Erna-Elise Paulsen, Sigurd M. Hald, Tom Donnem
Supplemental Table III. Prognostic clinicopathologic variables as predictors for Overall Survival in 797 NSCLS (univariate analyses,log-rank test)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::563165616b3850f85e7970ded50d780f
https://doi.org/10.1158/1078-0432.22459332.v1
https://doi.org/10.1158/1078-0432.22459332.v1
Autor:
Lill-Tove Busund, Roy M. Bremnes, Francesco Pezzella, Sigve Andersen, Torkjel M. Sandanger, Yury Kiselev, Khalid Al-Shibli, Olfred Hansen, Henrik J. Ditzel, Karen Ege Olsen, Mette Poehl, Marius Lund-Iversen, Aslaug Helland, Odd Terje Brustugun, Thomas K. Kilvaer, Samer Al-Saad, Elin Richardsen, Erna-Elise Paulsen, Sigurd M. Hald, Tom Donnem
Supplemental Figure 1. Disease-specific survival curves according to low, intermediate and high stromal CD8+ T-cell density in the Danish cohort (Odense University Hospital, n = 178). (A) Score from the invasive margin tumor area, (B) score from the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0d373c08aa378af6575ee6a9f4151253
https://doi.org/10.1158/1078-0432.22459341.v1
https://doi.org/10.1158/1078-0432.22459341.v1
Autor:
Lill-Tove Busund, Roy M. Bremnes, Francesco Pezzella, Sigve Andersen, Torkjel M. Sandanger, Yury Kiselev, Khalid Al-Shibli, Olfred Hansen, Henrik J. Ditzel, Karen Ege Olsen, Mette Poehl, Marius Lund-Iversen, Aslaug Helland, Odd Terje Brustugun, Thomas K. Kilvaer, Samer Al-Saad, Elin Richardsen, Erna-Elise Paulsen, Sigurd M. Hald, Tom Donnem
Supplemental Table I. Prognostic clinicopathologic variables as predictors for DSS in 797 NSCLS (univariate analyses,log-rank test)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2be43775f738c14a1317d1ac142258a7
https://doi.org/10.1158/1078-0432.22459338
https://doi.org/10.1158/1078-0432.22459338
Autor:
Marte Berglund, Simin Jamaly, Francesco Pezzella, Erna-Elise Paulsen, David J. Kwiatkowski, Lill-Tove Busund, Thomas Karsten Kilvær, Samer Al-Saad, Thomas Berg, Elin Richardsen, Tom Donnem, Sigve Andersen, Mehrdad Rakaee, Mette Poehl, Roy M. Bremnes
Publikováno v:
Br J Cancer
Background We previously proposed an immune cell score (tumour node metastasis (TNM)-Immune cell score) classifier as an add-on to the existing TNM staging system for non-small cell lung cancer (NSCLC). Herein, we examined how to reliably assess a te
Autor:
Yury Kiselev, Odd Terje Brustugun, Erna-Elise Paulsen, Thomas Karsten Kilvær, Lill-Tove Busund, Francesco Pezzella, Sigve Andersen, Roy M. Bremnes, Khalid Al-Shibli, Torkjel M. Sandanger, Elin Richardsen, Olfred Hansen, Sigurd M. Hald, Samer Al-Saad, Marius Lund-Iversen, Henrik J. Ditzel, Åslaug Helland, Karen Ege Olsen, Mette Poehl, Tom Donnem
Publikováno v:
Donnem, T, Hald, S M, Paulsen, E-E, Richardsen, E, Al-Saad, S, Kilvaer, T K, Brustugun, O T, Helland, A, Lund-Iversen, M, Poehl, M, Olsen, K E, Ditzel, H J, Hansen, O, Al-Shibli, K, Kiselev, Y, Sandanger, T M, Andersen, S, Pezzella, F, Bremnes, R M & Busund, L-T 2015, ' Stromal CD8+ T-cell Density—A Promising Supplement to TNM Staging in Non-Small Cell Lung Cancer ', Clinical Cancer Research, vol. 21, no. 11, pp. 2635-2643 . https://doi.org/10.1158/1078-0432.CCR-14-1905
Purpose: Immunoscore is a prognostic tool defined to quantify in situ immune cell infiltrates, which appears to be superior to the tumor–node–metastasis (TNM) classification in colorectal cancer. In non–small cell lung cancer (NSCLC), no immuno